Here’s Why Moderna’s CEO Isn’t Fazed by Its Cancer-Vaccine Selloff
Stéphane Bancel defended his melanoma data and argued that rivals can’t easily copy the technology.
We haven't written up this one. Hindustan Times - World News has the full story — the link below goes straight to it.